GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance
Monday, March 23, 2026 1 min read
Key Takeaway: GE HealthCare has announced that its Photonova Spectra photon-counting CT has received 510(k) clearance from the FDA. This advanced imaging solution features the company's Deep Silicon detector technology, providing ultra-high definition spatial and spectral imaging. The device is designed to be flexible, accommodating various clinical needs.
Market Sentiment Analysis
POSITIVE FACTORS
GE HealthCare received FDA clearance for Photonova Spectra.
The device utilizes innovative photon-counting technology.
It offers ultra-high definition imaging and flexible configurations.
Full Press Release Details
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ Spectra,i an innovative photon‑counting computed tomography (PCCT) solution powered by the company’s novel Deep Silicon detector technology and offered as a flexible platform with multiple configurations to meet diverse clinical needs. With wide coverage and the combination of ultra-high definition (UHD) spatial and spectral imaging, Photonova Spec
Frequently Asked Questions
What is Photonova Spectra?
Photonova Spectra is a photon-counting computed tomography solution by GE HealthCare.
What technology powers Photonova Spectra?
It is powered by GE HealthCare's novel Deep Silicon detector technology.
What does FDA clearance mean for Photonova Spectra?
FDA clearance indicates that Photonova Spectra meets safety and effectiveness standards.
What imaging capabilities does Photonova Spectra offer?
It provides ultra-high definition spatial and spectral imaging.